These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1822 related articles for article (PubMed ID: 28474673)

  • 1. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer.
    Chung W; Eum HH; Lee HO; Lee KM; Lee HB; Kim KT; Ryu HS; Kim S; Lee JE; Park YH; Kan Z; Han W; Park WY
    Nat Commun; 2017 May; 8():15081. PubMed ID: 28474673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.
    Cimino-Mathews A; Ye X; Meeker A; Argani P; Emens LA
    Hum Pathol; 2013 Oct; 44(10):2055-63. PubMed ID: 23701942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
    Bao X; Shi R; Zhao T; Wang Y; Anastasov N; Rosemann M; Fang W
    Cancer Immunol Immunother; 2021 Jan; 70(1):189-202. PubMed ID: 32681241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ER-/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple-negative breast cancer.
    Beltjens F; Molly D; Bertaut A; Richard C; Desmoulins I; Loustalot C; Charon-Barra C; Courcet E; Bergeron A; Ladoire S; Jankowski C; Boidot R; Arnould L
    Int J Cancer; 2021 Jul; 149(1):200-213. PubMed ID: 33634878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
    Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component.
    Avigdor BE; Beierl K; Gocke CD; Zabransky DJ; Cravero K; Kyker-Snowman K; Button B; Chu D; Croessmann S; Cochran RL; Connolly RM; Park BH; Wheelan SJ; Cimino-Mathews A
    Clin Cancer Res; 2017 Aug; 23(16):4875-4884. PubMed ID: 28424200
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.
    de Boo L; Cimino-Mathews A; Lubeck Y; Daletzakis A; Opdam M; Sanders J; Hooijberg E; van Rossum A; Loncova Z; Rieder D; Trajanoski Z; Vollebergh M; Sobral-Leite M; van de Vijver K; Broeks A; van der Wiel R; van Tinteren H; Linn S; Horlings HM; Kok M
    Eur J Cancer; 2020 Mar; 127():240-250. PubMed ID: 31956037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast.
    Zhao H; Chen D; Wang J; Yin Y; Gao Q; Zhang Y
    Int J Clin Exp Pathol; 2014; 7(2):670-6. PubMed ID: 24551288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local iron homeostasis in the breast ductal carcinoma microenvironment.
    Marques O; Porto G; Rêma A; Faria F; Cruz Paula A; Gomez-Lazaro M; Silva P; Martins da Silva B; Lopes C
    BMC Cancer; 2016 Mar; 16():187. PubMed ID: 26944411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the mechanism of heterogeneous tumor-associated macrophages in three subtypes of breast cancer through the integration of single-cell RNA sequencing and in vitro experiments.
    Yuan Y; Zhang S; Huang J
    Mol Biol Rep; 2024 Jun; 51(1):720. PubMed ID: 38824268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer.
    Mohammed ZM; Going JJ; Edwards J; Elsberger B; Doughty JC; McMillan DC
    Br J Cancer; 2012 Aug; 107(5):864-73. PubMed ID: 22878371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.
    Azizi E; Carr AJ; Plitas G; Cornish AE; Konopacki C; Prabhakaran S; Nainys J; Wu K; Kiseliovas V; Setty M; Choi K; Fromme RM; Dao P; McKenney PT; Wasti RC; Kadaveru K; Mazutis L; Rudensky AY; Pe'er D
    Cell; 2018 Aug; 174(5):1293-1308.e36. PubMed ID: 29961579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    Gao ZH; Li CX; Liu M; Jiang JY
    BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pan-cancer single-cell RNA-seq atlas of intratumoral B cells.
    Fitzsimons E; Qian D; Enica A; Thakkar K; Augustine M; Gamble S; Reading JL; Litchfield K
    Cancer Cell; 2024 Oct; 42(10):1784-1797.e4. PubMed ID: 39406187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence for concurrent morphological and genetic heterogeneity in an invasive ductal carcinoma of triple-negative phenotype.
    Patani N; Barbashina V; Lambros MB; Gauthier A; Mansour M; Mackay A; Reis-Filho JS
    J Clin Pathol; 2011 Sep; 64(9):822-8. PubMed ID: 21676924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer.
    Richard F; Majjaj S; Venet D; Rothé F; Pingitore J; Boeckx B; Marchio C; Clatot F; Bertucci F; Mariani O; Galant C; Eynden GVD; Salgado R; Biganzoli E; Lambrechts D; Vincent-Salomon A; Pruneri G; Larsimont D; Sotiriou C; Desmedt C
    Clin Cancer Res; 2020 Dec; 26(23):6254-6265. PubMed ID: 32943456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Profile of Breast Cancer Patients at a Tertiary Care Hospital in New Delhi, India.
    Doval DC; Sharma A; Sinha R; Kumar K; Dewan AK; Chaturvedi H; Batra U; Talwar V; Gupta SK; Singh S; Bhole V; Mehta A
    Asian Pac J Cancer Prev; 2015; 16(12):4959-64. PubMed ID: 26163622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer?
    Jones T; Neboori H; Wu H; Yang Q; Haffty BG; Evans S; Higgins S; Moran MS
    Ann Surg Oncol; 2013 Sep; 20(9):2866-72. PubMed ID: 23661183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of PTEN, p53 and EGFR in the molecular subtypes of breast carcinoma and 
the correlation among them].
    Li X; Wang Q; Fu L; Liu M; Yu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 40(9):973-8. PubMed ID: 26408616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.
    Waks AG; Stover DG; Guerriero JL; Dillon D; Barry WT; Gjini E; Hartl C; Lo W; Savoie J; Brock J; Wesolowski R; Li Z; Damicis A; Philips AV; Wu Y; Yang F; Sullivan A; Danaher P; Brauer HA; Osmani W; Lipschitz M; Hoadley KA; Goldberg M; Perou CM; Rodig S; Winer EP; Krop IE; Mittendorf EA; Tolaney SM
    Clin Cancer Res; 2019 Aug; 25(15):4644-4655. PubMed ID: 31061067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.